Nyxoah SA (EBR:NYXH)
6.74
-0.19 (-2.74%)
Last updated: Jun 2, 2025
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €248.14 million as of June 6, 2025. Its market cap has decreased by -9.83% in one year.
Market Cap
248.14M
Enterprise Value
207.18M
Revenue
4.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.74
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 248.14M, a decrease of -40.60%. That is a compound annual growth rate of -10.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 6, 2025 | 248.14M | -19.73% |
Dec 31, 2024 | 309.15M | 153.09% |
Dec 29, 2023 | 122.15M | -8.05% |
Dec 30, 2022 | 132.85M | -72.29% |
Dec 31, 2021 | 479.37M | 37.44% |
Dec 31, 2020 | 348.77M | -16.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 31.52B |
UCB SA | 30.93B |
Financière de Tubize | 5.80B |
Fagron NV | 1.61B |
Ion Beam Applications | 357.05M |
Onward Medical | 190.86M |
Hyloris Pharmaceuticals | 175.28M |
Sequana Medical NV | 51.23M |